Dr. Shalaby W. Shalaby founded Poly-Med, Inc. in Pendleton, South Carolina. His vision continues to drive our dedicated approach. Our company remains focused on the advancement of bioresorbable polymers for use in medical device and drug delivery applications.

Setting the framework for our distinctive strategy in vertical integration and unique product offerings, the first patent applications are filed. US Patents 5,898,040 and 5,969,020 “Microporous polymeric foams and microtextured surfaces” were granted from these initial applications. These original patents disclose novel materials and processes to generate substrates for the medical market.

Forming a relationship with a leading partner in the industry, the first product to utilize a Poly-Med, Inc. technology is launched. We worked with our partner to identify materials and process, and continue to support them through contract manufacturing today.

Poly-Med Inc.’s corporate offices and R&D operations merge under one roof. This expanded facility allows growth into new operations; including dedicated extrusion and coating facilities along with enhanced analytical capabilities.

Poly-Med opens a 14,000sf state-of-the-art facility dedicated to expanding manufacturing and quality demands. This new facility allows for more than double the manufacturing capabilities.

Our 100th patent application is submitted to the USPTO. US Patent 7,632,765 is granted from this application, disclosing inorganic-organic melted extruded fibers and constructs for use in advanced medical devices.

Highlighting Poly-Med, Inc.’s vertically integrated capabilities, the first hernia mesh utilizing our specialized polymers, extrusion, and knitting technologies is launched.

The first sustained release pharmaceutical, utilizing a proprietary Poly-Med polymer system, is officially launched in Germany. The polymeric base provides a stable, hydro-setting gel system to release the antibiotic doxycycline for 14 days.

Dr. Shalaby is awarded the Society for Biomaterials, C. William Hall lifetime achievement award. This esteemed award honors significant contributions to biomaterials science and education.

In continuing support of Clemson University’s increased graduate student research and education, Poly-Med Inc. proudly employs three adjunct faculty professors.

A molded fastener used for soft tissue fixation prepared from our Max-Prene® 955, is cleared for marketing. This marks the 15th product utilizing Poly-Med’s bioabsorbable technologies released into the marketplace.

In order to meet the increasing need for specialty engineering and manufacturing support, we are expanding. Our new state-of-the art facility will include additional offices and manufacturing areas for engineering, quality assurance, polymerization, textile conversion, and packaging.

Our company remains focused on the advancement of material solutions for medical device and drug delivery applications.

Poly-Med opens a new 30,000sf state-of-the-art facility dedicated to expanding manufacturing and development demands. This new facility allows for more than double the manufacturing capabilities at Poly-Med.